Marinus Pharmaceuticals, Inc. (MRNS)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	79	593	148	437	373	116
Market Cap Growth	44.14%	300.71%	-66.11%	17.02%	220.78%	0.04%
Enterprise Value	76	552	9	355	233	25
PE Ratio	-	-4.19	-7.47	-4.42	-4.89	-2.15
PS Ratio	2.78	19.14	5.81	28.46	217.26	-
PB Ratio	-30.06	35.38	1.28	8.17	2.72	1.95
P/FCF Ratio	-4.33	-5.02	-1.29	-7.48	-6.13	-2.37
P/OCF Ratio	-4.33	-5.03	-1.31	-7.87	-6.13	-2.39
EV/Sales Ratio	2.68	17.81	0.37	23.11	135.78	-
EV/EBITDA Ratio	-3.81	-4.40	-1.85	-3.71	-3.49	-0.46
EV/EBIT Ratio	-3.79	-4.38	-1.63	-3.69	-3.46	-0.46
EV/FCF Ratio	-4.31	-4.67	-0.08	-6.08	-3.83	-0.50
Debt / Equity Ratio	-6.73	6.50	0.88	0.76	-	-
Debt / EBITDA Ratio	-0.86	-0.87	-20.03	-0.43	-	-
Debt / FCF Ratio	-0.97	-0.92	-0.89	-0.70	-	-
Quick Ratio	2.73	3.79	9.87	3.10	13.20	11.42
Current Ratio	3.07	4.07	10.09	3.25	13.63	11.72
Asset Turnover	0.16	0.16	0.15	0.11	0.02	0
Interest Coverage	-7.59	-7.46	-0.54	-37.26	-	-
Return on Equity (ROE)	-518.10%	-264.60%	-32.60%	-115.40%	-82.80%	-109.40%
Return on Assets (ROA)	-81.90%	-70.70%	-11.40%	-71.20%	-68.20%	-79.80%
Return on Capital (ROIC)	-142.63%	-104.59%	-51.76%	-102.80%	-49.52%	-91.45%
Earnings Yield	-185.03%	-23.84%	-13.39%	-22.61%	-20.46%	-46.51%
FCF Yield	-145.25%	-19.91%	-77.34%	-13.36%	-16.32%	-42.13%
Buyback Yield / Dilution	-9.82%	-37.56%	-6.47%	-34.57%	-100.10%	-33.30%
Total Shareholder Return	-9.82%	-37.56%	-6.47%	-34.57%	-100.10%	-33.30%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).